- Home
- PAC vs HALO Comparison
PAC vs HALO Comparison
Compare PAC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAC
- HALO
- Stock Information
- Founded
- PAC 1998
- HALO 1998
- Country
- PAC Mexico
- HALO United States
- Employees
- PAC N/A
- HALO N/A
- Industry
- PAC Aerospace
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAC Consumer Discretionary
- HALO Health Care
- Exchange
- PAC Nasdaq
- HALO Nasdaq
- Market Cap
- PAC 8.1B
- HALO 7.7B
- IPO Year
- PAC 2006
- HALO N/A
- Fundamental
- Price
- PAC $176.99
- HALO $63.23
- Analyst Decision
- PAC Strong Buy
- HALO Buy
- Analyst Count
- PAC 2
- HALO 9
- Target Price
- PAC $170.00
- HALO $59.44
- AVG Volume (30 Days)
- PAC 69.6K
- HALO 1.2M
- Earning Date
- PAC 10-21-2024
- HALO 11-04-2024
- Dividend Yield
- PAC 3.44%
- HALO N/A
- EPS Growth
- PAC N/A
- HALO 51.77
- EPS
- PAC 1.00
- HALO 2.58
- Revenue
- PAC $1,340,452,608.00
- HALO $873,304,000.00
- Revenue This Year
- PAC $26.05
- HALO $21.07
- Revenue Next Year
- PAC $9.24
- HALO $16.24
- P/E Ratio
- PAC $17.41
- HALO $24.11
- Revenue Growth
- PAC N/A
- HALO 12.88
- 52 Week Low
- PAC $107.25
- HALO $32.83
- 52 Week High
- PAC $197.31
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- PAC 60.21
- HALO 63.51
- Support Level
- PAC $166.76
- HALO $58.59
- Resistance Level
- PAC $179.83
- HALO $62.81
- Average True Range (ATR)
- PAC 5.46
- HALO 1.77
- MACD
- PAC 0.31
- HALO -0.24
- Stochastic Oscillator
- PAC 85.37
- HALO 66.93
About PAC Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.